AMN Healthcare Services, Inc.

NYSE:AMN

Medical - Care Facilities

Healthcare
$37.60 -3.98%

-$1.29 today

Market cap
$1.45B
Beta
0.44
P/E (TTM)
-37.3
EPS (TTM)
-$0.83
52W Low $14.87High $33.13

Volume 0.55M

Average 1.02M

AMN Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

AMN Healthcare Services, Inc.NYSE: AMN

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables turns negative

Q1 FY2026 accounts receivables was -$14.19M, compared with $24.51M a year earlier. Trailing-twelve-month accounts receivables was $41.69M. Over 3 fiscal years it compounded at +55.1% a year.

Context

  • Accounts receivables amounted to 2.7% of revenue in FY2025, down 4.6 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts receivables holds near -$14.19M or moves back toward the trailing-twelve-month quarterly average of $10.42M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$14.19M-170.6% QoQ
Last fiscal yearDec 2025
$74.75M-65.9% YoY
LTMMar 2026
$41.69M-76.5% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-157.9%——
1 year-65.9%——
3-year CAGR+55.1%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
74.75M USD
Year-over-year change
-65.9%

Accounts Receivables vs competitors

How AMN compares with its peers on the latest reported figures

  • AMN's LTM Mar 2026 accounts receivables of $41.69M is the 3rd largest of the 11 companies compared; the peer median is $1.65M.
  • Its year-over-year change of -76.5% is the 7th highest of 10, against a peer median of -17.5%.
  • Accounts receivables amounts to 1.2% of revenue for AMN, versus a peer median of 2.3%.
AMN Competitors Peer median
Accounts Receivables for AMN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVHEvolent Health, Inc.LTM Mar 2026$85.22M +3185.5%—4.5%
NUTXNutex Health, Inc.LTM Mar 2026$46.51M -80.1%—5.3%
AMNAMN Healthcare Services, Inc.LTM Mar 2026$41.69M -76.5%+55.1%1.2%
HSTMHealthStream, Inc.LTM Mar 2026$7.53M -241.6%-20.0%2.4%
BFLYButterfly Network, Inc.LTM Mar 2026$6.2M -10.1%+30.2%6.0%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026$3.47M -166.1%—1.7%
MYGNMyriad Genetics, Inc.LTM Mar 2026$3.3M -17.5%-7.0%0.4%
DNAGinkgo Bioworks Holdings, Inc.LTM Mar 2026$2.98M +212.5%—2.1%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$1.39M +158.3%—0.9%
REPLReplimune Group, Inc.LTM Dec 2025$354K -70.4%——
CMPSCOMPASS Pathways plcLTM Mar 2026$0 ———
Peer median (excluding AMN) $1.65M-17.5%-7.0%2.3%

Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income327.39M444.05M210.68M(146.98M)(95.7M)
Depreciation & Amortization103.7M137.11M160.93M173.78M156.6M
Deferred Income Tax(16.29M)(24.62M)(12.93M)(51.07M)(19.55M)
Stock-Based Compensation25.22M30.07M18.02M23.32M30.68M
Change in Working Capital(143.49M)(558K)(50.13M)85.91M101.03M
Accounts Receivables(585.27M)20.04M224.85M219.44M74.75M
Inventory(256.12M)0000
Accounts Payables256.12M000(20.57M)
Other Working Capital441.77M(20.6M)(274.98M)(133.53M)46.85M
Other Non-Cash Items8.84M67.68M45.6M235.46M96.39M
Operating Cash Flow305.36M653.73M372.17M320.42M269.46M
Capital Expenditures(53.66M)(80.92M)(105.39M)(80.89M)(35.63M)
Acquisitions (Net)(41.26M)(69.5M)(292.1M)065.28M
Purchases of Investments(61.22M)(13.15M)0(1.38M)(36.15M)
Sales of Investments57.74M14.38M9.89M9.1M10.78M
Other Investing Activities(8.99M)(26.61M)(26.6M)(6.76M)22K
Investing Cash Flow(107.4M)(170.71M)(412.49M)(79.94M)4.3M
Debt Repayment(21.88M)0459.7M(250M)(285M)
Common Stock Issued00000
Common Stock Repurchased(2.69M)(576.77M)(424.74M)(8.48M)(2.09M)
Dividends Paid00000
Other Financing Activities(10.33M)(15.1M)(24.23M)(9.45M)(8.8M)
Financing Cash Flow(34.9M)(591.87M)10.73M(259.45M)(295.89M)
Effect of Forex Changes(335K)0000
Net Change in Cash162.72M(108.84M)(29.6M)(18.97M)(22.13M)
Free Cash Flow251.69M572.81M266.78M239.53M233.83M

AMN Healthcare Services, Inc.

NYSE:AMN

Intrinsic Alpha fair value

Locked

Current Price

$37.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.